Exercise retards development of liver cancer by direct effects independent of weight control in an animal model that closely resembles humans with fatty liver disease, report scientists in the Journal of Hepatology. Oxford, April 14, 2020 – Liver cancer is…
Professor Paolo Angeli has been elected Editor-in-Chief of the Journal of Hepatology – the flagship journal of the European Association for the Study of the Liver (EASL) Prof. Paolo Angeli was selected by the EASL Governing Board, with his appointment…
Whole-exome sequencing successfully diagnosed genetic cause of liver disease in one in four adults and could play a key role in timely diagnosis and treatment of adults with liver disease of unknown origin, report scientists in the Journal of Hepatology…
The latest journal from EASL, JHEP Reports is fully open access.Our goal is to become an essential channel for innovation in hepatology by publishing outstanding basic, translational and clinical studies.
A revision is proposed for current WHO guidelines for chronic hepatitis B (CHB) as they fail to detect half of the patients in need of treatment in Ethiopia
In a new study in the Journal of Hepatology, researchers report favorable 10-year survival rates for patients with HBV and/or HCV treated with antiviral agents and advise that antiviral therapy should be systematically offered to all HBV and HCV patients in line with international recommendations.
It is estimated that 2 billion people are infected with hepatitis B virus (HBV) globally, with 686,000 people dying from complications of the disease each year.
Hepatic encephalopathy (HE) is a frequent complication in patients with chronic liver disease. HE is a complication of cirrhosis that is associated with psychomotor slowing and an increased risk of accidents at home, at work, or while driving a car…
Before the advent of antiretroviral drugs, the prognosis for patients with AIDS was extremely poor. However, new antiretroviral treatments have revolutionised care for patients with HIV/AIDS, making lifelong viral suppression possible and improving life expectancy to near normal in patients…
Liver cancer is a leading cause of cancer death, with hepatocellular carcinoma (HCC) accounting for 85–90% of all primary liver cancers. In a recent issue of Journal of Hepatology, Dr Baumeister et al. showed that higher total physical activity was…